CRYOFOCUS-B (06922): Receives NMPA Approval for Registration Modification of Single-Use Cryoprobe in Cryoablation Adhesion Treatment System

Stock News
Aug 07

CRYOFOCUS-B (06922) announced that following the approval granted by the National Medical Products Administration (NMPA) on January 9, 2024, for other components (namely single-use cryoprobes) of the group's cryoablation adhesion treatment system, one of the group's respiratory intervention products, the registration modification from single-use cryoprobe to cryoprobe has received NMPA approval on August 5, 2025.

With the receipt of these approvals from the NMPA, the group's commercialization pathway for the cryoablation adhesion treatment system will be further enhanced, allowing the cryoprobe to provide comprehensive coverage for relevant indications with both single-use and reusable product characteristics.

The cryoablation adhesion treatment system employs subcritical refrigeration technology and controlled pressure heat transfer technology for rapid cryoablation adhesion. It will be used for the cryogenic removal of foreign objects, mucus, blood clots, and necrotic tissue within airways, as well as for cryobiopsy of bronchial and lung tissue.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10